DGAP-News

JUERGEN RATHS, MD APPOINTED AS CHIEF OPERATING OFFICER AT PAION AG

DGAP-News: PAION AG / Key word(s): Change of Personnel
JUERGEN RATHS, MD APPOINTED AS CHIEF OPERATING OFFICER AT PAION AG

27.08.2015 / 14:00

---------------------------------------------------------------------

JUERGEN RATHS, MD APPOINTED AS CHIEF OPERATING OFFICER AT PAION AG

- New COO brings wealth of experience in international product launches

- Responsible for the establishment of an efficient commercial structure

Aachen (Germany), 27 August 2015 - PAION AG, a Specialty Pharma Company
(ISIN DE000A0B65S3; Frankfurt Stock Exchange Prime Standard: PA8),
announces that Dr. Juergen Raths (59) has been appointed by the Supervisory
Board as a new member of the Management Board of PAION AG and will be Chief
Operating Officer with effect from 1 September 2015. Dr. Raths has been
working for PAION as a consultant since 2014 and will be responsible for
the establishment of the commercial structure to serve anesthetists in
Europe and around the world.

Dr. Raths has over 25 years of experience in the European and global pharma
business, with positions held in medical sales and marketing as well as
general management in Europe and the U.S He was Associate Partner with
Executive Insight, a Zurich-based pharma consultancy firm, focusing on
biotech, pharma and medical device companies. Dr. Raths focused on
supporting Pharma companies entering the European market. He formerly
served as President and CEO of private specialty pharmaceutical company
Correvio International in Geneva as well as President and CEO of publicly
traded Arpida AG based in Basel. Dr. Raths spent 18 years with Eli Lilly
and Company in various senior executive roles including Head Critical Care
Europe, and he spent three years at Corporate Headquarters in Indianapolis
in Health Economics and New Product Planning. He holds an MD from the
University of Bonn. Dr. Raths brings to PAION exceptional leadership
experience in company formation, change management and global business
development.

Dr. Jörg Spiekerkötter, Chairman of the Supervisory Board of PAION AG,
explained why Dr. Raths was the candidate of choice: "Our decision to
appoint Dr. Raths as COO aligns with our strategy to broaden the know-how
of the executive management of PAION for the future and to transform PAION
into a commercial-stage company. We are bringing on board an experienced
business executive with a strong background in global product launches. I
wish him every success in his new function."

"I have known Jürgen for many years and with his deep experience in